Cartalax Peptide Raw Powder

Cartalax is a short-chain bioregulatory peptide composed of three amino acids—Alanine, Glutamic Acid, and Aspartic Acid (Ala–Glu–Asp, AED)—designed to support the normalization and maintenance of the cartilage and spinal connective tissue system.

Send Inquiry

Product Introduction

Cartalax Peptide (Ala–Glu–Asp) | Cartilage & Connective Tissue Bioregulator

What Is Cartalax Peptide?

Cartalax is a short-chain bioregulatory peptide composed of three amino acids-Alanine, Glutamic Acid, and Aspartic Acid (Ala–Glu–Asp, AED)-designed to support the normalization and maintenance of the cartilage and spinal connective tissue system.

Through its regulatory action at the cellular level, Cartalax helps correct and prevent connective tissue imbalances associated with cartilage and spinal disorders. It is widely studied for its role in maintaining structural integrity, tissue regeneration, and functional stability of connective tissues affected by degenerative or pathological conditions.

Unlike hormones or growth factors, Cartalax works through subtle gene expression and cellular signaling modulation, making it a valuable compound for joint health, musculoskeletal, and regenerative research models.

Cartalax Peptide Mechanism of Action

01/

Gene Expression Modulation

Cartalax has been studied for its ability to influence transcriptional activity in cartilage-related cells, potentially supporting genes involved in:

Collagen production
ECM structural proteins
Cellular repair mechanisms

02/

Connective Tissue Regulation

In experimental models, Cartalax may help regulate:

Cartilage matrix stability
Fibroblast functional activity
Tissue remodeling processes

03/

Cellular Aging & Regeneration

Cartalax has been explored in aging tissue models for its potential role in:

Reducing apoptosis-associated signaling
Supporting normal cell cycle activity
Maintaining tissue homeostasis over time

⚠️ These effects are based on laboratory and preclinical research and are not clinically established.

What Makes Cartalax Different from Other Peptides?

Feature	Cartalax
Peptide length	Very short (3 amino acids)
Action type	Bioregulatory (gene signaling)
Hormonal effect	None
Growth factor	No
Target tissue	Cartilage & connective tissue
Molecular size	Extremely small, high stability

Cartalax does not act like anabolic peptides or hormones; instead, it belongs to a class of low-dose regulatory peptides aimed at restoring cellular balance.

Comparison With Other Regenerative Peptides

Peptide	Primary Focus	Mechanism Type
Cartalax	Cartilage & connective tissue	Gene signaling bioregulation
Epitalon	Aging & telomeres	Epigenetic regulation
Thymosin Beta-4	Tissue repair	Cell migration
GHK-Cu	Tissue remodeling	Growth signaling
BPC-157	Injury recovery	Cytoprotection

Cartalax stands out for its cartilage-specific regulatory profile.

FAQ

Q1: Is Cartalax a hormone or drug?
No. Cartalax is a bioregulatory research peptide and does not function as a hormone or pharmaceutical drug.

Q2: What tissues does Cartalax primarily target?
Research focuses on cartilage, joints, and connective tissues.

Q3: Can Cartalax be combined with other peptides?
Yes. It is often studied in combination with other regenerative or anti-aging peptides.

Q4: Is Cartalax approved for medical use?
No. It is strictly for laboratory and research purposes.

Safety & Disclaimer

This product is intended for research and laboratory use only.
Not for human or veterinary consumption, medical treatment, or cosmetic application.
Buyers are responsible for compliance with all applicable laws and regulations.